Ian Smith
Chairman at SOLID BIOSCIENCES INC.
Net worth: 1 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam Koppel | M | 54 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | 8 years |
| Jeffrey Leiden | M | 68 |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | 15 years |
| TY Howton | M | 52 | 6 years | |
| Douglas Cole | M | 63 | 9 years | |
| Reshma Kewalramani | M | 51 | 7 years | |
| Thomas Lynch | M | 63 | 8 years | |
| Alexander Cumbo | M | 53 | 6 years | |
| Ilan Ganot | M | 50 | 11 years | |
| Joshua Boger | M | 73 | 29 years | |
| Adrian Gottschalk | M | 49 | 7 years | |
| Huw Nash | M | 57 | 10 years | |
| Michael LaCascia | M | 59 | 9 years | |
| Kerry Clem | M | 54 | 13 years | |
| Seth Harrison | M | 63 | 9 years | |
| Martin Freed | M | 63 | 8 years | |
| Adrian Krainer | M | 65 | 10 years | |
| Jennifer Burstein | F | 52 | 15 years | |
| John Kelley | M | 70 | 16 years | |
| Lynne Sullivan | F | 58 | 9 years | |
| Jay Paul Corrigan | M | 53 |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | - |
| Raj Shah | M | 46 | 7 years | |
| Sukumar Nagendran | M | 58 | 6 years | |
| Arthur Tzianabos | M | 60 | 6 years | |
| Michael Mendelsohn | M | 69 | 7 years | |
| Ricky Sun | M | 50 |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | 8 years |
| Arthur Levin | M | 70 | 9 years | |
| Adam Stone | M | 44 | 9 years | |
| Kris Miller | M | 58 |
The Financial Executives Institute
| - |
| Sangeeta Bhatia | M | 55 | 9 years | |
| Isabel Aznarez | M | 52 | 10 years | |
| Stuart Arbuckle | M | 58 | 12 years | |
| Garry Menzel | M | 59 | 4 years | |
| Leonide Saad | M | - | - | |
| Harris Weber | M | - |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | 7 years |
| Julie Smith | F | 53 | 4 years | |
| Dawn Kalmar | F | 47 | 14 years | |
| Adrian D. Shelley | M | - |
The Financial Executives Institute
| - |
| Amit Sachdev | M | 56 | 17 years | |
| Amir Zamani | M | - |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | 6 years |
| B. Parshall | F | 70 | 2 years | |
| Mark O. Eisele | M | 66 |
The Financial Executives Institute
| - |
| Mark Foletta | M | 63 |
The Financial Executives Institute
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | 15 years |
| Jonathan Allan | M | - | - | |
| Alan Garber | M | 68 | 7 years | |
| Joy Liu | F | - | 8 years | |
| Edward Kaye | M | 75 | 7 years | |
| Michael Greene | M | - |
iVexSol, Inc.
 iVexSol, Inc. Medical SpecialtiesHealth Technology iVexSol, Inc. engages in operation of a viral vector manufacturing firm. It provides lentiviral vectors (LVV), a gene delivery vehicles that are a critical component in the manufacturing of life-changing cell and gene therapies (CGTs). The company was founded by Rodney L. Rietze and is headquartered in Boston, MA. | - |
| Clare Khan | M | 72 | 3 years | |
| Ken Goldman | M | 73 |
The Financial Executives Institute
| - |
| Simba Gill | M | 60 | 7 years | |
| Harry J. Cynkus | M | 74 |
The Financial Executives Institute
| - |
| Fanny Cavalié | F | 46 | - | |
| David Altshuler | M | 59 | 12 years | |
| Norman Selby | M | 71 | 12 years | |
| Steven Bellon | M | 59 | 8 years | |
| Rodney L Rietze | M | - |
iVexSol, Inc.
iVexSol, Inc. Medical SpecialtiesHealth Technology iVexSol, Inc. engages in operation of a viral vector manufacturing firm. It provides lentiviral vectors (LVV), a gene delivery vehicles that are a critical component in the manufacturing of life-changing cell and gene therapies (CGTs). The company was founded by Rodney L. Rietze and is headquartered in Boston, MA. | 5 years |
| Georgia Keresty | M | 62 | 3 years | |
| Annie Ganot | F | - | 11 years | |
| Peder Jensen | M | 69 | 13 years | |
| David W. Beier | M | 75 | 6 years | |
| Janet Haugen | F | 65 |
The Financial Executives Institute
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | 17 years |
| Ronald Renaud | M | 55 |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | 2 years |
| Allen Hagerman | M | 72 |
The Financial Executives Institute
| - |
| Nicholas Downing | M | 39 |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | 6 years |
| Scott Biller | M | 68 | 4 years | |
| George MacKenzie | M | 75 |
The Financial Executives Institute
| - |
| James J. Sheppard | M | - |
The Financial Executives Institute
| - |
| Aladin Mawani | M | 72 |
The Financial Executives Institute
| - |
| Blaine A. Robinson | M | 64 |
The Financial Executives Institute
| - |
| Bruce J. Biemeck | M | 75 |
The Financial Executives Institute
| - |
| Robert J. Bahash | M | 79 |
The Financial Executives Institute
| - |
| Richard Allen | M | 67 |
The Financial Executives Institute
| - |
| Lionel Nowell | M | 69 |
The Financial Executives Institute
| - |
| William R. Graber | M | 80 |
The Financial Executives Institute
| - |
| John Mills | M | 76 |
The Financial Executives Institute
| - |
| C. Bruce Burton | M | - |
The Financial Executives Institute
| - |
| Dowd Thomas | M | - |
The Financial Executives Institute
| - |
| William A. Morrow | M | - |
The Financial Executives Institute
| - |
| Mark B. Rinder | M | - |
The Financial Executives Institute
| - |
| Robert S. Gluck | M | 74 |
The Financial Executives Institute
| - |
| M. Scott Chapline | M | - |
The Financial Executives Institute
| - |
| Joseph Dailey | M | - |
The Financial Executives Institute
| - |
| Cassie J. Belmonte | F | - |
The Financial Executives Institute
| - |
| John Partington | M | - |
The Financial Executives Institute
| - |
| David Chou | M | - |
The Financial Executives Institute
| 22 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lawrence Bloch | M | 58 | 11 years | |
| Stephen DiPalma | M | 66 | 3 years | |
| Christopher M. Lindblom | M | 52 | 8 years | |
| Gerald Quirk | M | 56 | 6 years | |
| Joel Schneider | M | 39 | 8 years | |
| Samir Chandrakant Patel | M | 62 | 10 years | |
| Matthew Emmens | M | 72 | - | |
| Paul Silva | M | 58 | 14 years | |
| Paul Laikind | M | 68 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 8 years |
| Michael Kauffman | M | 60 |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | 8 years |
| Michael Yang | M | 62 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | - |
| Matthew Bennett Arnold | M | 55 | 8 years | |
| Samuel Agresta | M | 51 | 5 years | |
| Robert Morales | M | 57 | 7 years | |
| Simon Bedson | M | 62 |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 99.00% |
| United Kingdom | 1 | 1.00% |
| Canada | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ian Smith
- Personal Network
